摘要 |
<p>The present invention is based, at least in part, on the discovery and validation of specific immunogenic peptide epitopes for various HLA class II DR molecules, representative of the worldwide population. Such peptides comprise an epitope, or analog thereof, which binds to an HLA class II molecule at an IC50 of less than or equal to 1,000 nM.</p> |